Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP940848.RAoQidlRHUO_i6GOVNlBOvMN_beaprbrzU6AOC4_Du1lY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP940848.RAoQidlRHUO_i6GOVNlBOvMN_beaprbrzU6AOC4_Du1lY130_assertion type Assertion NP940848.RAoQidlRHUO_i6GOVNlBOvMN_beaprbrzU6AOC4_Du1lY130_head.
- NP940848.RAoQidlRHUO_i6GOVNlBOvMN_beaprbrzU6AOC4_Du1lY130_assertion description "[drug accumulation, MDR1 P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and topoisomerase (topo) II, to drug resistance in a large set of drug-resistant variants of the human non-small-cell lung cancer cell line SW-1573 derived by selection with low concentrations of doxorubicin or vincristine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP940848.RAoQidlRHUO_i6GOVNlBOvMN_beaprbrzU6AOC4_Du1lY130_provenance.
- NP940848.RAoQidlRHUO_i6GOVNlBOvMN_beaprbrzU6AOC4_Du1lY130_assertion evidence source_evidence_literature NP940848.RAoQidlRHUO_i6GOVNlBOvMN_beaprbrzU6AOC4_Du1lY130_provenance.
- NP940848.RAoQidlRHUO_i6GOVNlBOvMN_beaprbrzU6AOC4_Du1lY130_assertion SIO_000772 7640209 NP940848.RAoQidlRHUO_i6GOVNlBOvMN_beaprbrzU6AOC4_Du1lY130_provenance.
- NP940848.RAoQidlRHUO_i6GOVNlBOvMN_beaprbrzU6AOC4_Du1lY130_assertion wasDerivedFrom befree-20150227 NP940848.RAoQidlRHUO_i6GOVNlBOvMN_beaprbrzU6AOC4_Du1lY130_provenance.
- NP940848.RAoQidlRHUO_i6GOVNlBOvMN_beaprbrzU6AOC4_Du1lY130_assertion wasGeneratedBy ECO_0000203 NP940848.RAoQidlRHUO_i6GOVNlBOvMN_beaprbrzU6AOC4_Du1lY130_provenance.